ARTICLE | Financial News
Antigenics files $100 million shelf
November 27, 2001 8:00 AM UTC
AGEN, which is in Phase III testing of its Oncophage cancer vaccine, filed a shelf registration covering the sale of up to $100 million of securities. AGEN, which had $71.7 million in cash as of Sept....